Dalteparin

🧮 Dose calculator

Acute coronary syndrome / post-MI · Regimen source: FDA Fragmin · 2.1

• • With aspirin 75–165 mg daily until clinically stable. FDA Fragmin · 2.1

Enter age and weight.

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Fragmin · 8.1

  “Risk Summary Available data from published literature and postmarketing reports have not reported a clear association with FRAGMIN and adverse developmental outcomes.”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Fragmin · 8.2

  “Risk Summary Limited published data indicate that dalteparin is present in human milk in small amounts (see Data ) .”

• 👶 ChildrenUse with caution

  The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Fragmin · 8.4

  “The safety and effectiveness of FRAGMIN for the treatment of symptomatic venous thromboembolism (VTE) in patients have been established in pediatric patients from birth (gestational age at least 35 weeks) to less than 17 years of age.”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Fragmin · 8.5

  “… ticularly in those with low body weight (<45 kg) and those predisposed to decreased renal function [see Warnings and Precautions (5) and Clinical Pharmacology (12) ] .”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.